[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sab Biotherapeutics Inc (SABS)

Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sab Biotherapeutics Inc 777 W 41st St Suite 401 Miami Beach FL 33140 USA

www.sab.bio Employees: 86 P: 605-679-6980

Sector:

Medical

Description:

SAB Biotherapeutics Inc. is a clinical-stage biopharmaceutical company advancing a new class of immunotherapies leveraging fully human polyclonal antibodies. It produces natural, specifically targeted, high-potency, human polyclonal immunotherapies. SAB Biotherapeutics Inc., formerly known as Big Cypress Acquisition Corp., is based in SIOUX FALLS, S.D.

Key Statistics

Overview:

Market Capitalization, $K 268,389
Enterprise Value, $K 257,889
Shares Outstanding, K 76,464
Float, K 70,813
% Float 92.61%
Short Interest, K 3,773
Short Float 4.94%
Days to Cover 2.70
Short Volume Ratio 0.52
% of Insider Shareholders 7.39%
% of Institutional Shareholders 7.82%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ 13,270 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -18,870 K
EBIT, $ -58,180 K
EBITDA, $ -55,190 K

Growth:

1-Year Return 38.33%
3-Year Return -58.28%
5-Year Return -96.46%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.35 on 05/12/26
Next Earnings Date 08/06/26 [--]
Earnings Per Share ttm -2.11
EPS Growth vs. Prev Qtr 23.91%
EPS Growth vs. Prev Year 37.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/05/24

SABS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -0.29%
Return-on-Assets % -0.25%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow 10.36
Price/Book 1.18
Book Value/Share 3.00
Interest Coverage 56.29
60-Month Beta 0.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.